Literature DB >> 22458739

A simplified mechanistic algorithm for treating resistant hypertension: efficacy in a retrospective study.

Samuel J Mann1, Neal S Parikh.   

Abstract

This retrospective study assessed the efficacy of a recently described, mechanism-based algorithm for treating resistant hypertension. Charts of consecutive patients seen for resistant hypertension were reviewed. Algorithm-based intervention was limited to either or both of just 2 options: (1) strengthening of the diuretic regimen, usually with addition of spironolactone; and (2) treatment with the combination of an α- + nonmetabolized β-blocker. Of 27 patients, 24 (89%) achieved control, including 13 (54%) in whom the diuretic regimen was strengthened, 6 (25%) in whom α-/β-blockade was instituted, and 5 (21%) who received both interventions. The most frequent medication adjustments were addition of a potassium-sparing diuretic in 16 (67%), doxazosin in 9 (37.5%), and replacing a metabolized with a nonmetabolized β-blocker in 6 (25%). The authors conclude that treatment based on this algorithm can both simplify and improve the management of resistant hypertension and merits further evaluation in prospective studies.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22458739      PMCID: PMC8108948          DOI: 10.1111/j.1751-7176.2012.00605.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  30 in total

1.  Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials.

Authors:  Franz H Messerli; Harikrishna Makani; Alexandre Benjo; Jorge Romero; Carlos Alviar; Sripal Bangalore
Journal:  J Am Coll Cardiol       Date:  2011-02-01       Impact factor: 24.094

Review 2.  Refractory hypertension.

Authors:  J F Setaro; H R Black
Journal:  N Engl J Med       Date:  1992-08-20       Impact factor: 91.245

3.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

4.  Chronic dose-response curve of enalapril in essential hypertensives. An Italian multicenter study.

Authors:  A Salvetti; F Arzilli
Journal:  Am J Hypertens       Date:  1989-05       Impact factor: 2.689

5.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

6.  Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial.

Authors:  M Searle; R Dathan; S Dean; C C Christensen; A Westheim
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 7.  Neurogenic essential hypertension revisited: the case for increased clinical and research attention.

Authors:  Samuel J Mann
Journal:  Am J Hypertens       Date:  2003-10       Impact factor: 2.689

8.  Telmisartan, ramipril, or both in patients at high risk for vascular events.

Authors:  Salim Yusuf; Koon K Teo; Janice Pogue; Leanne Dyal; Ingrid Copland; Helmut Schumacher; Gilles Dagenais; Peter Sleight; Craig Anderson
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

9.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

Review 10.  Resistant hypertension: prevalence and evolving concepts.

Authors:  Murray Epstein
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-01       Impact factor: 3.738

View more
  7 in total

Review 1.  Neurogenic hypertension: pathophysiology, diagnosis and management.

Authors:  Samuel J Mann
Journal:  Clin Auton Res       Date:  2018-07-04       Impact factor: 4.435

Review 2.  Treatment resistant hypertension--investigation and conservative management.

Authors:  Franz Weber; Manfred Anlauf
Journal:  Dtsch Arztebl Int       Date:  2014-06-20       Impact factor: 5.594

3.  Measure accurately, Act rapidly, and Partner with patients: An intuitive and practical three-part framework to guide efforts to improve hypertension control.

Authors:  Romsai T Boonyasai; Michael K Rakotz; Lisa H Lubomski; Donna M Daniel; Jill A Marsteller; Kathryn S Taylor; Lisa A Cooper; Omar Hasan; Matthew K Wynia
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-03-23       Impact factor: 3.738

4.  American Society of Hypertension Scientific Statements Addressing Resistant Hypertension.

Authors:  J Rick Turner; John Lee
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-14       Impact factor: 3.738

5.  Improved blood pressure control in the hands of the hypertension specialist: method, magic, or something in between?

Authors:  Louis Kuritzky
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-06-25       Impact factor: 3.738

Review 6.  Exploring issues in difficult-to-treat hypertension.

Authors:  Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-10-30       Impact factor: 3.738

7.  Psychosomatic research in hypertension: the lack of impact of decades of research and new directions to consider.

Authors:  Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-07-26       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.